亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The tricks for fighting against cancer using CAR NK cells: A review

嵌合抗原受体 NK-92 生物 免疫学 癌症研究 免疫系统
作者
Fatemeh Vahidian,Leila Mohamed Khosroshahi,Moloud Akbarzadeh,Ali Jahanban-Esfahlan,Amir Baghbanzadeh,Mohammad Ali-Hassanzadeh,Elham Safarzadeh
出处
期刊:Molecular and Cellular Probes [Elsevier]
卷期号:: 101817-101817 被引量:2
标识
DOI:10.1016/j.mcp.2022.101817
摘要

Natural killer (NK) cells seem to be the most common innate lymphocyte subtypes, and they're known for their ability to guide anti-tumor and anti-viral responses, making them potentially therapeutic. Since NK cells lack polymorphic clonotypic receptors, they must rely on inhibitory receptors to develop, mature, and distinguish between "self" and "non-self." In the clinic, genetically engineered immune cells expressing a chimeric antigen receptor (CAR) that consists of an extracellular antigen recognizing domain connected to an intracellular signaling domain have gained interest. The U.S. food and drug administration (FDA) approved two CAR-T cells, anti-CD19 CARs, for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL). Nevertheless, CAR-T cell therapy is linked to a series of negative side effects, including fatal cytokine release syndrome (CRS) and tumor lysis syndrome (TLS), as well as a lack of regulatory control. CAR-transduced NK cells (CAR-NK) are thought to have many benefits, including clinical safety, the mechanisms by which they identify cancerous cells, and their abundance in clinical specimens, according to a growing number of studies. In pre-clinical and clinical trials, human primary NK cells and the NK-92 cell line were effectively transduced to express CARs against hematological cancers and solid tumors. Here, it is tried to summarize the development of CAR-NK cells, challenges and coping strategies, as well as managing the challenges and obstacles related to its protection, which promises to eliminate the shortcomings of conventional CARs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
1分钟前
郜南烟发布了新的文献求助10
1分钟前
SciGPT应助郜南烟采纳,获得10
1分钟前
Meredith完成签到,获得积分10
4分钟前
4分钟前
郜南烟发布了新的文献求助10
4分钟前
舒心豪英完成签到 ,获得积分10
5分钟前
5分钟前
6分钟前
郜南烟发布了新的文献求助10
6分钟前
可爱的函函应助郜南烟采纳,获得10
6分钟前
Miracle完成签到,获得积分10
7分钟前
Claire完成签到 ,获得积分10
7分钟前
充电宝应助圆圆的波仔采纳,获得100
8分钟前
舒心远侵发布了新的文献求助10
9分钟前
可爱的函函应助舒心远侵采纳,获得10
9分钟前
zoie0809完成签到,获得积分10
9分钟前
Emperor完成签到 ,获得积分0
9分钟前
舒心远侵完成签到,获得积分10
9分钟前
天天快乐应助高小羊采纳,获得10
12分钟前
12分钟前
高小羊发布了新的文献求助10
12分钟前
打打应助郜南烟采纳,获得10
12分钟前
高小羊完成签到,获得积分10
12分钟前
LouieHuang完成签到,获得积分20
13分钟前
13分钟前
郜南烟发布了新的文献求助10
13分钟前
wanci应助郜南烟采纳,获得10
13分钟前
上官若男应助zhangyimg采纳,获得10
13分钟前
13分钟前
Lorin完成签到 ,获得积分10
14分钟前
14分钟前
zhangyimg发布了新的文献求助10
14分钟前
科目三应助zhangyimg采纳,获得10
14分钟前
gszy1975完成签到,获得积分10
15分钟前
圆圆的波仔发布了新的文献求助100
15分钟前
JamesPei应助科研通管家采纳,获得10
16分钟前
郗妫完成签到,获得积分10
16分钟前
17分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146771
求助须知:如何正确求助?哪些是违规求助? 2798063
关于积分的说明 7826647
捐赠科研通 2454573
什么是DOI,文献DOI怎么找? 1306394
科研通“疑难数据库(出版商)”最低求助积分说明 627708
版权声明 601527